Aurobindo Pharma has announced the resignation of Dr. Sanjay Chaturvedi from his position as Chief Executive Officer of Apitoria Pharma Private Limited, a wholly owned subsidiary of the company. Dr. Chaturvedi has decided to pursue a different opportunity, and his resignation is effective from the close of business hours on 4 May 2026.
Dr. Chaturvedi’s departure marks a significant change in the leadership of Apitoria Pharma, which operates under the umbrella of Aurobindo Pharma. The company has not yet announced a successor for the CEO position at Apitoria Pharma.
Aurobindo Pharma is a prominent player in the pharmaceutical industry, known for its extensive range of generic medications and active pharmaceutical ingredients. The company continues to expand its global footprint and enhance its product offerings.
Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).